Health Care [ 9/12 ] | Biotechnology [ 61/74 ]
NASDAQ | Common Stock
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States.
The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman for the prediction of the expectant mother's risk of delivering spontaneously.
It is also developing a pipeline of novel blood-based biomarker tests for major pregnancy-related conditions, including time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction.
The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 20, 25 | -0.25 Increased by 0.00% | -0.24 Decreased by -4.17% |
| Nov 7, 24 | -0.24 Decreased by -4.35% | -0.22 Decreased by -9.09% |
| Aug 8, 24 | -0.25 Increased by +26.47% | -0.27 Increased by +5.66% |
| May 8, 24 | -0.25 Increased by +26.47% | -0.27 Increased by +7.41% |
| Mar 20, 24 | -0.25 Increased by +19.35% | -0.26 Increased by +3.85% |
| Nov 8, 23 | -0.23 Increased by +34.29% | -0.34 Increased by +32.35% |
| Aug 9, 23 | -0.34 Increased by +8.11% | -0.36 Increased by +5.56% |
| May 10, 23 | -0.34 Increased by +15.00% | -0.38 Increased by +10.53% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 24 | 24.00 K Decreased by -41.46% | -8.58 M Decreased by -8.25% | Decreased by -35.75 K% Decreased by -84.93% |
| Sep 30, 24 | 29.00 K Decreased by -30.95% | -7.92 M Decreased by -9.83% | Decreased by -27.31 K% Decreased by -59.07% |
| Jun 30, 24 | 24.00 K Decreased by -80.49% | -8.30 M Increased by +21.24% | Decreased by -34.60 K% Decreased by -303.65% |
| Mar 31, 24 | 0.00 Decreased by -100.00% | -8.10 M Increased by +17.52% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 41.00 K Decreased by -36.92% | -7.92 M Increased by +19.02% | Decreased by -19.33 K% Decreased by -28.39% |
| Sep 30, 23 | 42.00 K Decreased by -51.72% | -7.21 M Increased by +29.16% | Decreased by -17.17 K% Decreased by -46.74% |
| Jun 30, 23 | 123.00 K Increased by +57.69% | -10.54 M Increased by +6.66% | Decreased by -8.57 K% Increased by +40.81% |
| Mar 31, 23 | 100.00 K Increased by +163.16% | -9.82 M Increased by +18.97% | Decreased by -9.82 K% Increased by +69.21% |